Clinical Trial Update: Glycoprotein in Immunotherapy Response and Efficacy Prediction of Lung Cancer

View source ↗

Summary

A recruiting clinical trial at Shanghai Chest Hospital is evaluating a glycoprotein as a biomarker to predict immunotherapy response and efficacy in non-small c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Non Small Cell Lung Cancer | Status: RECRUITING